Cyclopent[a]anthraquinones as DNA-intercalating agents with covalent bond formation potential: Synthesis and biological activity

Journal of Medicinal Chemistry

Volumn 39, Issue 14, 1996, Pages 2812-2818

  Kim, Joong Young ^a   Su, Tsann Long ^b   Chou, Ting Chao ^a   Koehler, Bernd ^a   Scarborough, Alex ^a   Ouerfelli, Ouathek ^a   Watanabe, Kyoichi A ^a  

^a Department of Obstetrics Gynecology   (United States)

^b INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAQUINONE; AZIRIDINE DERIVATIVE; DNA TOPOISOMERASE; DOUBLE STRANDED DNA; ENZYME INHIBITOR; MITOMYCIN C;

ARTICLE; COVALENT BOND; CYCLIZATION; DNA BINDING; DNA DETERMINATION; LUNG ADENOCARCINOMA; PROTEIN SYNTHESIS; STRUCTURE ACTIVITY RELATION;

ANIMALS; ANTHRAQUINONES; ANTINEOPLASTIC AGENTS; CELL LINE; CRICETINAE; DNA; DRUG SCREENING ASSAYS, ANTITUMOR; HL-60 CELLS; HUMANS; INTERCALATING AGENTS; MITOMYCIN; MITOMYCINS; MOLECULAR STRUCTURE; TUMOR CELLS, CULTURED;

EID: 0009138586     PISSN: 00222623     EISSN: None     Source Type: Journal    
DOI: 10.1021/jm950881y     Document Type: Article

References (26)

1. Satorelli, A. C. Therapeutic attack of solid tumors. Cancer Res. 1988, 48, 775-778.
2. Oostveen, E. A.; Speckamp, W. N. Mitomycin analogs I. Indoloquinones as potential bisalkylating agents. Tetrahedron 1987, 43, 255-262.
3. Carter, S. K.; Crooke, S. T. Mitomycin C: Current Status and New Developments; Academic Press: New York, 1979.
4. Tomasz, M.; Lipman, R.; Chowdary, D.; Pawlak, J.; Verdine, G. L.; Nakanishi, K.; Isolation and structure of a covalently cross-linked adduct between mitomycin C and DNA. Science 1987, 235, 1204-1208.
5. Hendriks, H. R.; Pizo, P. E.; Berger, D. P.; Kooistra, K. L.; Bibby, M. C.; Boven, E.; Dreef-van der Meulen, H. C.; Henrar, R. E. C.; Fiebig, H. H.; Double, J. A.; Hornstra, H. W.; Pinedo, H. M.; Workman, P.; Schwartmann, G. E09: A novel bioreductive alkylating indoloquinone with preferential solid tumor activity and lack of bone marrow toxicity in preclinical models. Eur. J. Cancer 1993, 29A, 897-906.
6. Walton, M. I.; Smith, P. J.; Workman, P. The role of NAD(P)H: quinone reductase (EC 1.6.99.2, DT-Diaphorase) in the reductive bioactivation of the novel indoloquinone antitumor agent E09. Cancer Commun. 1991, 3, 199-206.
7. Koyama, M.; Kelly, T. R.; Watanabe, K. A. Novel type of potential anticancer agents derived form chrysophanol and emodine. Some structure-activity relationship studies. J. Med. Chem. 1988, 31, 283-284.
8. Gourdie, T. A.; Prakash, A. S.; Wakelin, L. P. G.; Woodgate, P. D.; Denny, W. A. Synthesis and evaluation of DNA-targeted spatially separated bis(aniline mustards) as potential alkylating agents with enhanced DNA cross-linking capability. J. Med. Chem. 1991, 34, 240-248.
9. Köhler, B.; Su, T.-L.; Chou, T.-C.; Jiang, X.-J.; Watanabe, K. A. Synthesis of cyclopentanthraquinones: Analogues of mitomycin C. J. Org. Chem. 1993, 58, 1680-1686.
10. Horita, K.; Yoshioka, T.; Tanaka, T.; Oikawa, Y.; Yonemitsu, O. On the selectivity of deprotection of benzyl, MPM (4-methoxy-benzyl) and DMPM (3,4-dimethoxybenzyl) protecting groups for hydroxy functions. Tetrahedron 1986, 42, 3021-3028.
11. English, J., Jr.; Babaer, G. W. The synthesis of some 1-cyclo-pentenealdehydes. J. Am. Chem. Soc. 1949, 71, 3310-3313.
12. Still, W. C. Stannylation/destannylation. Preparation of α-alkoxy organolithium reagents and synthesis of dendrolasin via a carbinyl carbanion equivalent. J. Am. Chem. Soc. 1978, 100, 1481-1487.
13. Seyferth, D.; Andrews, B. Halomethyl-metal compounds. Preparation of monohalomethyl derivatives of germanium, tin, lead and mercury via halomethylzinc halides. J. Organomet. Chem. 1971, 30, 151-166.
14. Marquez, V. E.; Bodenteich, M. Psicoplanocin A. A synthetic carbocyclic nucleoside with the combined structural features of neplanocin A and psicofuranine. Nucleosides Nucleotides 1991, 10, 311-314.
15. Ayral-kaloustian, S.; Floyd, M. B., Jr. Synthesis of partially-protected D-fructofuranoses and D-fructose-6-phosphates. Carbohydr. Res. 1991, 214, 187-192.
16. Islam, I.; Skibo, B. Synthesis and physical studies of azamitosene and iminoamitosene reductive alkylating agents. Iminoquinone hydrolytic stability, syn/anti isomerization, and electrochemistry. J. Org. Chem. 1990, 55, 3195-3205.
17. van Rijsbergen, R.; Anteunis, M. J. O.; De Bruyn, A. Selective removal of the isopropylidene group in O-protected 1,6-anhydro-2,3-O-isopropylidene-β-D-mannopyranose and the conformational impact of it. Carbohydr. Chem. 1983, 2, 395-404.
18. Fisher, L. M.; Kuroda, R.; Sakai, T. T. Interaction of bleomycin A2 with deoxyribonucleic acid: DNA unwinding and inhibition of bleomycin-induced DNA breakage by cationic thiazole amides related to bleomycin A2. Biochemistry 1985, 24, 3199-3207.
19. Atwell, G. J.; Cain, B. F.; Seelye, R. N. Potential antitumor agents. 12. 9-Anilinoacridine. J. Med. Chem. 1972, 15, 611-615.
20. Su, T.-L.; Chou, T.-C.; Kim, J. Y.; Huang, J.-T.; Ciszewska, G.; Ren, W.-Y.; Otter, G. M.; Sirotnack, F. M.; Watanabe, K. A. 9-Substituted acridine derivatives with long half-life and potential antitumor activity. Synthesis and structure-activity relationships. J. Med. Chem. 1995, 38, 3226-3236.
21. Simpson, L.; Berliner, J.; Isolation of the kinetoplast DNA of Leishmania tarentolae in the form of a network. J. Protozoal. 1974, 27, 382-393.
22. Scudieo, D. A.; Shoemaker, R. H.; Paull, K. D.; Monk, A.; Tierney, S.; Nofziger, T. H.; Currens, M. J.; Seniff, D.; Boyd, M. R. Evaluation of soluble tetrazolium/formazean assay for cell growth and drug sensitivity in culture using human and other cell lines. Cancer Res. 1988, 48, 4827-4833.
23. Skehan, P.; Storeng, R.; Scudiero, D.; Monks, A.; McMahon, J.; Vistica, D.; Warren, J. T.; Bokesch, H.; Kenney, S.; Boyd, M. R. New colorimetric cytotoxicity assay for anticancer-drug screening. J. Natl. Cancer Inst. 1990, 82, 1107-1112.
24. Chou, T.-C.; Talalay, P.; Quantitative analysis of dose-effect relationships: the combined effects of multiple drugs or enzyme inhibitors. Adv. Enzyme Regul. 1984, 22, 27-55.
25. Chou, J.; Chou, T.-C. Dose-effect analysis with microcomputers: Quantitation of ED50, LD50, synergism, antagonism, low-dose risk, receptor-ligands binding and enzyme kinetics; Biosoft: Cambridge, UK, 1987.
26. Estey, E. H.; Silberman, B. M.; Anderson, B. S.; Zwelling, L. A. The interaction between nuclear topoisomerase II activity from human leukeima cells, exogenous DNA, and m-AMSA or VP-16 indicates the sensitivity of the cells to the drugs. Biockem. Biophys. Res. Commun. 1987, 144, 787-793.